APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicardipine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nicardipine Hydrochloride Injection Industry Growth and Trends Forecast to 2032

2 January 2026107 pages

Choose your research edition.

Industry ResearchNicardipine Hydrochloride Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicardipine Hydrochloride Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nicardipine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicardipine Hydrochloride Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicardipine Hydrochloride Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nicardipine Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicardipine Hydrochloride Injection include Chiesi, DMS Pharmaceutical, Hikma, Navinta, Sun Pharma, Wockhardt, Baxter, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nicardipine Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nicardipine Hydrochloride Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicardipine Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicardipine Hydrochloride Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nicardipine Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nicardipine Hydrochloride Injection Market by Company

Chiesi

DMS Pharmaceutical

Hikma

Navinta

Sun Pharma

Wockhardt

Baxter

Mylan

Sandoz

Shanghai Furen Medicine

Teva

Nicardipine Hydrochloride Injection Segment by Type

20mg/200 mL

40mg/200 mL

Nicardipine Hydrochloride Injection Segment by Application

Clinic

Hospital

Recovery Center

Nicardipine Hydrochloride Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicardipine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicardipine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicardipine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicardipine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nicardipine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20mg/200 mL Table 2. Major Company of 40mg/200 mL Table 3. Global Nicardipine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 5. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Nicardipine Hydrochloride Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Nicardipine Hydrochloride Injection Sales by Type (2027-2032) & (W Units) Table 10. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nicardipine Hydrochloride Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Nicardipine Hydrochloride Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 15. North America Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 17. Europe Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 21. Latin America Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Nicardipine Hydrochloride Injection Industry Trends Table 25. Nicardipine Hydrochloride Injection Industry Drivers Table 26. Nicardipine Hydrochloride Injection Industry Opportunities and Challenges Table 27. Nicardipine Hydrochloride Injection Industry Restraints Table 28. Global Nicardipine Hydrochloride Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company (2021-2026) Table 30. Global Nicardipine Hydrochloride Injection Sales by Company (2021-2026) & (W Units) Table 31. Global Nicardipine Hydrochloride Injection Sales Share by Company (2021-2026) Table 32. Global Nicardipine Hydrochloride Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Nicardipine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nicardipine Hydrochloride Injection Major Company Production Sites and Headquarters Table 35. Global Nicardipine Hydrochloride Injection Company, Product Type & Application Table 36. Global Nicardipine Hydrochloride Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nicardipine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nicardipine Hydrochloride Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nicardipine Hydrochloride Injection Sales by Region (2021-2026) & (W Units) Table 41. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nicardipine Hydrochloride Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Nicardipine Hydrochloride Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Nicardipine Hydrochloride Injection Sales by Region (2027-2032) & (W Units) Table 46. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nicardipine Hydrochloride Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Nicardipine Hydrochloride Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Nicardipine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 52. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Nicardipine Hydrochloride Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Nicardipine Hydrochloride Injection Sales by Application (2027-2032) & (W Units) Table 57. Global Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nicardipine Hydrochloride Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nicardipine Hydrochloride Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Nicardipine Hydrochloride Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 62. North America Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 64. Europe Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 68. Latin America Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Chiesi Company Information Table 72. Chiesi Business Overview Table 73. Chiesi Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chiesi Nicardipine Hydrochloride Injection Product Portfolio Table 75. Chiesi Recent Development Table 76. DMS Pharmaceutical Company Information Table 77. DMS Pharmaceutical Business Overview Table 78. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Portfolio Table 80. DMS Pharmaceutical Recent Development Table 81. Hikma Company Information Table 82. Hikma Business Overview Table 83. Hikma Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Nicardipine Hydrochloride Injection Product Portfolio Table 85. Hikma Recent Development Table 86. Navinta Company Information Table 87. Navinta Business Overview Table 88. Navinta Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Navinta Nicardipine Hydrochloride Injection Product Portfolio Table 90. Navinta Recent Development Table 91. Sun Pharma Company Information Table 92. Sun Pharma Business Overview Table 93. Sun Pharma Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sun Pharma Nicardipine Hydrochloride Injection Product Portfolio Table 95. Sun Pharma Recent Development Table 96. Wockhardt Company Information Table 97. Wockhardt Business Overview Table 98. Wockhardt Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Wockhardt Nicardipine Hydrochloride Injection Product Portfolio Table 100. Wockhardt Recent Development Table 101. Baxter Company Information Table 102. Baxter Business Overview Table 103. Baxter Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Baxter Nicardipine Hydrochloride Injection Product Portfolio Table 105. Baxter Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mylan Nicardipine Hydrochloride Injection Product Portfolio Table 110. Mylan Recent Development Table 111. Sandoz Company Information Table 112. Sandoz Business Overview Table 113. Sandoz Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sandoz Nicardipine Hydrochloride Injection Product Portfolio Table 115. Sandoz Recent Development Table 116. Shanghai Furen Medicine Company Information Table 117. Shanghai Furen Medicine Business Overview Table 118. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Portfolio Table 120. Shanghai Furen Medicine Recent Development Table 121. Teva Company Information Table 122. Teva Business Overview Table 123. Teva Nicardipine Hydrochloride Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Teva Nicardipine Hydrochloride Injection Product Portfolio Table 125. Teva Recent Development Table 126. North America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. North America Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 128. North America Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 129. North America Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (W Units) Table 130. North America Nicardipine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 131. North America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Nicardipine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Nicardipine Hydrochloride Injection Market Share by Country (2021-2026) Table 134. North America Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Nicardipine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 136. Europe Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Europe Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 138. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 139. Europe Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (W Units) Table 140. Europe Nicardipine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Nicardipine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Nicardipine Hydrochloride Injection Market Share by Country (2021-2026) Table 144. Europe Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Nicardipine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 148. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (W Units) Table 150. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Nicardipine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Nicardipine Hydrochloride Injection Market Share by Country (2021-2026) Table 154. Asia-Pacific Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Nicardipine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 156. Latin America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Latin America Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 158. Latin America Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 159. Latin America Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (W Units) Table 160. Latin America Nicardipine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Nicardipine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Nicardipine Hydrochloride Injection Market Share by Country (2021-2026) Table 164. Latin America Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Nicardipine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 168. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (W Units) Table 170. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Nicardipine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Nicardipine Hydrochloride Injection Market Share by Country (2021-2026) Table 174. Middle East and Africa Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Nicardipine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Nicardipine Hydrochloride Injection Distributors List Table 179. Nicardipine Hydrochloride Injection Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Nicardipine Hydrochloride Injection Image Figure 2. Global Nicardipine Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicardipine Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicardipine Hydrochloride Injection Sales (2021-2032) & (W Units) Figure 5. 20mg/200 mL Image Figure 6. Global 20mg/200 mL Sales YoY Growth (2021-2032) & (W Units) Figure 7. 40mg/200 mL Image Figure 8. Global 40mg/200 mL Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Nicardipine Hydrochloride Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nicardipine Hydrochloride Injection Market Share by Type 2025 VS 2032 Figure 11. North America Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Nicardipine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nicardipine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nicardipine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nicardipine Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Nicardipine Hydrochloride Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Nicardipine Hydrochloride Injection Market Share by Application 2025 VS 2032 Figure 31. North America Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Nicardipine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Nicardipine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Nicardipine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Nicardipine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Nicardipine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Nicardipine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Nicardipine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nicardipine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Nicardipine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nicardipine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nicardipine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Nicardipine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nicardipine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Nicardipine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nicardipine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Nicardipine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nicardipine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nicardipine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Nicardipine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nicardipine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Nicardipine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Nicardipine Hydrochloride Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Nicardipine Hydrochloride Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg/200 mL
  • 40mg/200 mL
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Chiesi
  • DMS Pharmaceutical
  • Hikma
  • Navinta
  • Sun Pharma
  • Wockhardt
  • Baxter
  • Mylan
  • Sandoz
  • Shanghai Furen Medicine
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicardipine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicardipine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nicardipine Hydrochloride Injection Market by Type
  6. 1.3.1 20mg/200 mL
  7. 1.3.2 40mg/200 mL
  8. 1.4 Global Nicardipine Hydrochloride Injection Market Size by Type
  9. 1.4.1 Global Nicardipine Hydrochloride Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nicardipine Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nicardipine Hydrochloride Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nicardipine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nicardipine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nicardipine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nicardipine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nicardipine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nicardipine Hydrochloride Injection Industry Trends
  2. 2.2 Nicardipine Hydrochloride Injection Industry Drivers
  3. 2.3 Nicardipine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Nicardipine Hydrochloride Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nicardipine Hydrochloride Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Nicardipine Hydrochloride Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Nicardipine Hydrochloride Injection Price (2021-2026)
  4. 3.4 Global Nicardipine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicardipine Hydrochloride Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Nicardipine Hydrochloride Injection Company, Product Type & Application
  7. 3.7 Global Nicardipine Hydrochloride Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicardipine Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicardipine Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicardipine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Nicardipine Hydrochloride Injection Regional Status and Outlook
  1. 4.1 Global Nicardipine Hydrochloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nicardipine Hydrochloride Injection Historic Market Size by Region
  3. 4.2.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nicardipine Hydrochloride Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nicardipine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nicardipine Hydrochloride Injection Forecasted Market Size by Region
  7. 4.3.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nicardipine Hydrochloride Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nicardipine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicardipine Hydrochloride Injection by Application
  1. 5.1 Nicardipine Hydrochloride Injection Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Nicardipine Hydrochloride Injection Market Size by Application
  6. 5.2.1 Global Nicardipine Hydrochloride Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nicardipine Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nicardipine Hydrochloride Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nicardipine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nicardipine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nicardipine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nicardipine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nicardipine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chiesi
  2. 6.1.1 Chiesi Company Information
  3. 6.1.2 Chiesi Business Overview
  4. 6.1.3 Chiesi Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chiesi Nicardipine Hydrochloride Injection Product Portfolio
  6. 6.1.5 Chiesi Recent Developments
  7. 6.2 DMS Pharmaceutical
  8. 6.2.1 DMS Pharmaceutical Company Information
  9. 6.2.2 DMS Pharmaceutical Business Overview
  10. 6.2.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Portfolio
  12. 6.2.5 DMS Pharmaceutical Recent Developments
  13. 6.3 Hikma
  14. 6.3.1 Hikma Company Information
  15. 6.3.2 Hikma Business Overview
  16. 6.3.3 Hikma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Nicardipine Hydrochloride Injection Product Portfolio
  18. 6.3.5 Hikma Recent Developments
  19. 6.4 Navinta
  20. 6.4.1 Navinta Company Information
  21. 6.4.2 Navinta Business Overview
  22. 6.4.3 Navinta Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Navinta Nicardipine Hydrochloride Injection Product Portfolio
  24. 6.4.5 Navinta Recent Developments
  25. 6.5 Sun Pharma
  26. 6.5.1 Sun Pharma Company Information
  27. 6.5.2 Sun Pharma Business Overview
  28. 6.5.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharma Nicardipine Hydrochloride Injection Product Portfolio
  30. 6.5.5 Sun Pharma Recent Developments
  31. 6.6 Wockhardt
  32. 6.6.1 Wockhardt Company Information
  33. 6.6.2 Wockhardt Business Overview
  34. 6.6.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wockhardt Nicardipine Hydrochloride Injection Product Portfolio
  36. 6.6.5 Wockhardt Recent Developments
  37. 6.7 Baxter
  38. 6.7.1 Baxter Company Information
  39. 6.7.2 Baxter Business Overview
  40. 6.7.3 Baxter Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Baxter Nicardipine Hydrochloride Injection Product Portfolio
  42. 6.7.5 Baxter Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Nicardipine Hydrochloride Injection Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Sandoz
  50. 6.9.1 Sandoz Company Information
  51. 6.9.2 Sandoz Business Overview
  52. 6.9.3 Sandoz Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sandoz Nicardipine Hydrochloride Injection Product Portfolio
  54. 6.9.5 Sandoz Recent Developments
  55. 6.10 Shanghai Furen Medicine
  56. 6.10.1 Shanghai Furen Medicine Company Information
  57. 6.10.2 Shanghai Furen Medicine Business Overview
  58. 6.10.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Portfolio
  60. 6.10.5 Shanghai Furen Medicine Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Nicardipine Hydrochloride Injection Product Portfolio
  66. 6.11.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Nicardipine Hydrochloride Injection Sales by Country
  2. 7.1.1 North America Nicardipine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nicardipine Hydrochloride Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nicardipine Hydrochloride Injection Market Size by Country
  6. 7.2.1 North America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nicardipine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nicardipine Hydrochloride Injection Sales by Country
  2. 8.1.1 Europe Nicardipine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nicardipine Hydrochloride Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nicardipine Hydrochloride Injection Market Size by Country
  6. 8.2.1 Europe Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nicardipine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nicardipine Hydrochloride Injection Sales by Country
  2. 9.1.1 Asia-Pacific Nicardipine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nicardipine Hydrochloride Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nicardipine Hydrochloride Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nicardipine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nicardipine Hydrochloride Injection Sales by Country
  2. 10.1.1 South America Nicardipine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nicardipine Hydrochloride Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nicardipine Hydrochloride Injection Market Size by Country
  6. 10.2.1 South America Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nicardipine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country
  2. 11.1.1 Middle East and Africa Nicardipine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nicardipine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nicardipine Hydrochloride Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Nicardipine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nicardipine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nicardipine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nicardipine Hydrochloride Injection Value Chain Analysis
  2. 12.1.1 Nicardipine Hydrochloride Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nicardipine Hydrochloride Injection Production Mode & Process
  7. 12.2 Nicardipine Hydrochloride Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nicardipine Hydrochloride Injection Distributors
  10. 12.2.3 Nicardipine Hydrochloride Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst